Important Study Suggests that Rotational Atherectomy Is Feasible with Transradial Access

Rotational atherectomy is a very important tool in the treatment of heavily calcified and non-dilatable lesions. Historically, transfemoral access has been the gold standard due to a perceived need for large-bore guidewire catheters in order to use spheroids for proper debulking.

Según este importante estudio, la aterectomía rotacional es factible por acceso radial

Nowadays, rotational atherectomy has evolved towards a technique that aims to modify plaque for subsequent complete successful balloon dilatation, rather than complete debulking (which was the objective a few years ago). This shift in the technique allows for the use of smaller spheroids and, in turn, guidewire catheters that can be used in the radial artery.


Read also: Transradial Access and Early Discharge in Percutaneous Interventions”.


Between 2005 and 2014, a total of 8622 patients underwent rotational atherectomy in the United Kingdom. In 3069 of these procedures, physicians used a transradial access and in 5553, a transfemoral access.

 

Propensity scores were calculated in order to balance out the differences between populations.


Read also: Though on the Rise, the Transradial Approach to Primary PCI Remains Underused”.


The rates of death at 30 days (the primary endpoint for this study) were 2.2% with a transradial access vs. 2.3% with a transfemoral access (p = 0.76). Not only was transradial access associated with equivalent mortality rates, but also with similar procedural success rates (odds ratio [OR]: 1.04; p = 0.73) and similar rates for major cardiac and cerebrovascular events (OR: 1.05; p = 0.72), when compared with those for patients in whom transfemoral access was used. The clear advantages of transradial access were observed in lower rates of in-hospital major bleeding (OR: 0.62; p = 0.04) and lower rates of access-site complications (OR: 0.05; p = 0.004).

 

Conclusion

This is the real-life study that has included the largest group of patients with rotational atherectomy. In this population, transradial access offered similar rates of mortality and technical success, but significantly lower rates of minor bleeding and vascular complications, when compared with transfemoral access.

 

Editorial

The absence of benefit in terms of mortality may reflect the fact that most patients included were chronic and stable.

 

Despite traditional interventional conceptions, rotational atherectomies through transradial access were carried out without any problems.

 

A 6-French guidewire catheter easily allows for 1.25- or 1.5-mm spheroids, thus providing a spheroid to artery ratio of 0.5-0.6 for most vessels. Spheroid size is mostly aimed at modifying plaque and breaking calcium concentric rings, in almost all cases. Should a more aggressive ablation be necessary, with 1.75- or 2-mm spheroids, physicians could directly use a 7-French guidewire catheter, supported by most radial arteries.

 

Original title: Radial Versus Femoral Access for Rotational Atherectomy. A UK Observational Study of 8622 Patients.

Reference: Jonathan Watt et al. Circ Cardiovasc Interv. 2017 Dec;10(12).


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...